Double-blind, placebo-controlled study of the efficacy of reboxetine and citalopram as adjuncts to atypical antipsychotics for negative symptoms of schizophrenia

1. Usall, J.
2. López-Carrilero, R.
3. Iniesta, R.
4. Roca, M.
5. Caballero, M.
6. Rodriguez-Jimenez, R.
7. Oliveira, C.
8. Bernardo, M.
9. Corripio, I.
10. Sindreu, S.D.
11. Piqueras, J.C.G.
12. Felipe, A.E.
13. De Corres, B.F.
14. Ibáñez, A.
15. Huerta, R.